Drug Type Small molecule drug |
Synonyms DBPR 112, DBPR-112, DBPR112 |
Mechanism EGFR T790M inhibitors(EGFR T790M inhibitors), EGFR exon 21 L858R mutation inhibitors, HER2 exon 20 inhibitors(ERBB2 Exon 20 Mutation inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePhase 1 |
First Approval Date- |
Regulation- |
Molecular FormulaC32H31N5O3 |
InChIKeyNQAMTZUVRFRJCZ-VMMYIZNOSA-N |
CAS Registry1226549-49-0 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Head and Neck Neoplasms | Phase 1 | - | - | |
Lung Cancer | Phase 1 | - | - |
Phase 1 | - | dxwxbqaanf(unvvahwser) = zizdywyfev naegistmbs (ffvirkynwu ) | Positive | 01 Oct 2014 | |||
Not Applicable | - | naozdcriop(fgjgnvrtfs) = bvrlaxvpdy dsohceknre (ylmhgubbze ) View more | - | 29 Oct 2013 |